Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension

Diabetes Care

Volumn 21, Issue 4, 1998, Pages 631-636

  Giugliano, Dario ^a,b   Marfella, Raffaele ^a   Acampora, Rita ^a   Giunta, Riccardo ^a   Coppola, Ludovico ^a   D'Onofrio, Felice ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CARVEDILOL; PERINDOPRIL;

ADULT; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; ENDOTHELIUM; FEMALE; HEMODYNAMICS; HUMAN; HYPERTENSION; LEG BLOOD FLOW; MALE; MEAN ARTERIAL PRESSURE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ARGININE; BLOOD PRESSURE; BLOOD VISCOSITY; CARBAZOLES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; INDOLES; LEG; MALE; MIDDLE AGED; PERINDOPRIL; PLATELET AGGREGATION; PROPANOLAMINES; REFERENCE VALUES; REGIONAL BLOOD FLOW; RHEOLOGY; VASCULAR RESISTANCE;

EID: 0031922168     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.4.631     Document Type: Article

References (43)

1. Furchgott RF, Vanhoutte PM: Endothelium-derived relaxing and contracting factors. FASEB J 3:2007-2018, 1989
2. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012, 1993
3. Creager MC, Cooke JP, Mendelshon ME, Gallagher SG, Coleman SM, Loscalzo J, Dzau DJ: Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 86:228-234, 1990
4. Benjamin N, Vane J: Nitric oxide and hypertension. Circulation 94:1197-1198, 1996
5. Saenz de Tejada I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA: Impaired neurogenic and endothelium-mediated relaxation in penile smooth muscle from diabetic men with impotence. N Engl J Med 320:1025-1030, 1989
6. Kanno K, Hirata Y, Emori T, Ohta K, Eguchi S, Imai T, Marumo F: L-Arginine infusion induces hypotension and diuresis natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in humans. Clin Exp Pharmacol Physiol 19:619-625, 1992
7. Bode-Boger SM, Boger RH, Creutzig A, Tsikas D, Gutzhi F-M, Alexander R, Frolich JC: L-Arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin Sci 87:303-310, 1994
8. Giugliano D, Marfella R, Verrazzo G, Acampora R, Coppola L, Cozzolino D, D'Onofrio F: The vascular effects of L-arginine in humans: the role of endogenous insulin. J Clin Invest 99:433-438, 1997
9. Giugliano D, Marfella R, Verrazzo G, Acampora R, Nappo F, Ziccardi P, Coppola L, D'Onofrio F: L-Arginine for testing endothelial-dependent vascular function in health and disease. Am J Phystol 36:E606-E612, 1997
10. Sowers JR, Epstein M: Diabetes mellitus and associated hypertension, vascular disease and nephropathy: an update. Hypertension 26:869-879, 1995
11. Desta B, Vanhoutte PM, Boulanger CM: Inhibition of the angiotensin converting enzyme by perindoprilat and release of nitric oxide. Am J Hypertens 8:1S-6S, 1995
12. Yue T-L, McKenna PJ, Ruffolo RR Jr, Feuerstein G: Carvedilol, a new beta-adrenergic antagonist and vasodilator antihypertensive drug, inhibits Superoxide release from human neutrophils. Eur J Pharmacol 97:209-216, 1992
13. Calver A, Collier J, Vallance P: Forearm blood flow responses to a nitric oxide synthase inhibitor in patients with treated essential hypertension. Cardiovasc Res 28:1720-1725, 1994
14. G-monomethyl-L-arginine in patients with essential hypertension. J Hypertens 12:1047-1052, 1994
15. Parati G, Casadei R, Groppelli A, Di Rienzo M, Mancia G: Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension 13:647-655, 1989
16. Bos WJW, van Goudoever J, van montfrans GA, van den Meiraker AH, Wesseling KH: Reconstruction of brachial artery pressure from noninvasive finger pressure measurements. Circulation 94:1870-1875, 1996
17. Born AV: Aggregation of blood platelets by adenosindiphosphate and its reversal. Nature 94:927-929, 1962
18. Reid HL, Barnes AJ, Lock PJ, Dormandy JA, Dormandy TL: A simple method for measuring erythrocyte deformability. J Clin Pathol 29:855-858, 1976
19. Paolisso G, Giugliano D, Scheen AJ, D'Onofrio F, Lefebvre PJ: Primary role of glucagon release in the effect of beta-endorphin on glucose homeostasis in normal man. Acta Endocrinol 115:161-169, 1987
20. Watts GF, O'Brien SF, Silvester W, Millar JA: Impaired endothelium-dependent and independent dilation of forearm resistance arteries in men with diet-treated noninsulin dependent diabetes: role of dyslipidaemia. Clin Sci 91:567-573, 1996
21. Stehouwer CDA, Nauta JJP, Zeldenrust GC, Hackeng WHL, Donker AJM, Den Ottolander GJH: Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin dependent diabetes mellitus. Lancet 340:319-322, 1992
22. Vita JA, Treasure CB, Nabel KG, McLenacham JM, Fish RD, Yeung AC, Vekshtein VI, Seluyn AP, Ganz P: Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 81:491-497, 1990
23. Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali JR: Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 42:1017-1025, 1993
24. Kharitonov A, Lubec G, Lubec B, Hjelm M, Barnes PJ: L-arginine increases exhaled nitric oxide in normal human subjects. Clin Sci 88:135-139, 1995
25. Forstermann U, Closs EI, Pollock JS, Nakane M, Schwarz P, Gath I, Kleinert H: Nitric oxide synthase isozymes: characterization, purification, molecular cloning, and functions. Hypertension 23:1121-1131, 1994
26. Arnal J-F, Munzel T, Venema RC, James ML, Bay C-I, Mitch WE, Harrison DG: Interactions between L-arginine and L-glutamine change endothelial NO production: an effect independent of NO synthase substrate availability J Clin Invest 95:2565-2572, 1995
27. The National High Blood Pressure Education Program Working Group: National High Blood Pressure Education Program Working Group report on hypertension and diabetes. Hypertension 23:145-158, 1994
28. Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 19:257-267, 1996
29. Alexander RW: Hypertension and the pathogenesis of atherosclerosis: oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 25:155-161, 1995
30. Rajagopalau S, Kurz S, Munzel T, Tarpey M, Freer an BA, Griendling KK, Harrison DG: Angiotensin II-mediated hypertension in the rat increases vascular Superoxide production via membrane NADH/NADPH oxidase activation. J Clin Invest 97:1916-1923, 1996
31. Carretaro OA: Angiotensin converting enzyme inhibitors and endothelial dysfunction. Am J Hypertens 8:42S-44S, 1995
32. Campbell DJ, Kladis A, Duncan AM: Bradykinin peptides in kidney, blood, and other tissues of the rat. Hypertension 21:155-165, 1994
33. Wiemer G, Scholkens BA, Linz W: Endothelial protection by converting enzyme inhibitors. Cardiovasc Res 28:166-172, 1994
34. Kalil RSN, Katz SA, Keane WF: Angiotensin converting enzyme inhibitors in diabetes mellitus. In The Renin-Angiotensin System. Robertson JTS, Nicholls MG, Eds. London, Gower Medical, 1992, p, 1-20
35. Mombouli JV, Vanhoutte PM: Kinins and the vascular actions of ACE-inhibitors. Curr Op Nephrol Hypertens 3:481-484, 1994
36. McTavish D, Campoli-Richards K, Sorkin EM: Carvedilol: a review of its pharmacodynamics, pharmacokinetic properties and therapeutic efficacy. Drugs 45:232-258, 1993
37. Feuerstein GZ, Ruffolo RR Jr: Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection. Eur Heart J 16 (Suppl. F):38-42, 1995
38. Zeiher AM: Endothelial vasodilator dysfunction: pathogenetic link to myocardial ischaemia or epiphenomenon? Lancet 348 (Suppl. 1):s10-s12, 1996
39. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
40. Baron AD: Hemodynamic actions of insulin. Am J Physiol 267:E187-E202, 1994
41. Giugliano D, De Rosa N, Marfella R, Di Maro G, Cacciapuoti F, Quatraro A, Acampora R, D'Onofrio F: Comparison of nitrendipine and cilazapril in patients with hypertension and non-insulin-dependent diabetes mellitus. Am J Hypertens 6:927-932, 1993
42. Jacob S, Rett K, Vicklmayr M, Agrawal B, Augustin HJ, Dietze G-J: Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study. J Hypertens 14:489-494, 1996
43. Paolisso G, Giugliano D: Oxidative stress and insulin action: is there a relationship? Diabetologia 39:357-363, 1996